ReviewAdvances in experimental medicine and biology2024
Neurosurgery and the Brain-Computer Interface.
Review in Advances in experimental medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Application and Research Progress of BCI in Post-Stroke Psychiatric Disorders: A Narrative Review.Medical science monitor : international medical journal of experimental and clinical research · 2026Review
- [Research progress on flexible electrode technology in brain computer interface applications].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain-computer interfaces (BCIs) are devices that connect the human brain to an effector via a computer and electrode interface. BCIs may also transmit sensory data to the brain. We describe progress with the many types of surgically implanted BCIs, in which electrodes contact or penetrate the cerebral cortex. BCIs developed for restoration of movement in paralyzed limbs or control a robotic arm; restoration of somatic sensation, speech, vision, memory, hearing, and olfaction are also presented. Most devices remain experimental. Commercialization is costly, incurs financial risk, and is time consuming. There are many ethical principles that should be considered by neurosurgeons and by all those responsible for the care of people with serious neurological disability. These considerations are also paramount when the technology is used in for the purpose of enhancement of normal function and where commercial gain is a factor. A new regulatory and legislative framework is urgently required. The evolution of BCIs is occurring rapidly with advances in computer science, artificial intelligence, electronic engineering including wireless transmission, and materials science. The era of the brain-"cloud" interface is approaching.
Indexed as
Identifiers
39523287What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.